AI-driven analysis of chest x-rays is shown to be a cost-effective method for osteoporosis screening in U.S. women over 50.
Key Details
- 1Researchers evaluated opportunistic osteoporosis screening by applying deep learning to chest x-rays in women 50+.
- 2A two-part economic model compared costs and health outcomes between AI-enabled screening and no screening scenarios.
- 3Five million individual simulations informed projections for costs, fractures, life years, and QALYs.
- 4AI-enabled screening had a cost per QALY gained of $72,085, below the U.S. $100,000 benchmark for cost-effectiveness.
- 5AI screening resulted in more QALYs and fewer fractures but increased treatment costs.
Why It Matters
Demonstrating cost-effectiveness is crucial for policy, reimbursement, and adoption of radiology AI tools. The study supports expanding opportunistic AI-based screening to close osteoporosis care gaps and improve public health outcomes.
Source
AuntMinnie
Related News
•Health Imaging
Most FDA-Cleared AI Devices Lack Pre-Approval Safety Data, Study Finds
A new study finds fewer than 30% of FDA-cleared AI medical devices reported key safety or adverse event data before approval.
•Health Imaging
BMI Significantly Impacts AI Accuracy in CT Lung Nodule Detection
New research demonstrates that high BMI negatively impacts both human and AI performance in chest low-dose CT interpretation, highlighting dataset diversity concerns.
•AuntMinnie
AI for Breast Cancer Screening Not Cost-Effective, Study Finds
AI-assisted breast cancer screening showed minor clinical benefits over DBT alone but was not cost-effective at standard willingness-to-pay thresholds.